{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T01:16:48Z","timestamp":1790990208006,"version":"4.1.0"},"reference-count":267,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T00:00:00Z","timestamp":1675296000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Gastric cancer predominantly occurs in adenocarcinoma form and is characterized by uncontrolled growth and metastases of gastric epithelial cells. The growth of gastric cells is regulated by the action of several major cell cycle regulators including Cyclins and Cyclin-dependent kinases (CDKs), which act sequentially to modulate the life cycle of a living cell. It has been reported that inadequate or over-activity of these molecules leads to disturbances in cell cycle dynamics, which consequently results in gastric cancer development. Manny studies have reported the key roles of Cyclins and CDKs in the development and progression of the disease in either in vitro cell culture studies or in vivo models. We aimed to compile the evidence of molecules acting as regulators of both Cyclins and CDKs, i.e., upstream regulators either activating or inhibiting Cyclins and CDKs. The review entails an introduction to gastric cancer, along with an overview of the involvement of cell cycle regulation and focused on the regulation of various Cyclins and CDKs in gastric cancer. It can act as an extensive resource for developing new hypotheses for future studies.<\/jats:p>","DOI":"10.3390\/ijms24032848","type":"journal-article","created":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T02:21:12Z","timestamp":1675304472000},"page":"2848","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["The Regulation of Cyclins and Cyclin-Dependent Kinases in the Development of Gastric Cancer"],"prefix":"10.3390","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9098-2340","authenticated-orcid":false,"given":"Aadil","family":"Javed","sequence":"first","affiliation":[{"name":"Department of Bioengineering, Faculty of Engineering, Cancer Biology Laboratory, Ege University, Izmir 35040, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahdieh","family":"Yarmohammadi","sequence":"additional","affiliation":[{"name":"Department of Biology, Faculty of Sciences, Central Tehran Branch, Islamic Azad University, Tehran 33817-74895, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kemal Sami","family":"Korkmaz","sequence":"additional","affiliation":[{"name":"Department of Bioengineering, Faculty of Engineering, Cancer Biology Laboratory, Ege University, Izmir 35040, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5331-4244","authenticated-orcid":false,"given":"Teresa","family":"Rubio-Tom\u00e1s","sequence":"additional","affiliation":[{"name":"School of Medicine, University of Crete, 70013 Herakleion, Crete, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,2,2]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1002\/ijc.31937","article-title":"Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods","volume":"144","author":"Ferlay","year":"2019","journal-title":"Int. J. Cancer"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.cgh.2019.07.045","article-title":"Burden of Gastric Cancer","volume":"18","author":"Thrift","year":"2020","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"734","DOI":"10.21037\/atm.2020.03.166","article-title":"The burden of gastric cancer","volume":"8","author":"Hamashima","year":"2020","journal-title":"Ann. Transl. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1093\/gastro\/goab010","article-title":"Gastrointestinal cancers in China, the USA, and Europe","volume":"9","author":"Xie","year":"2021","journal-title":"Gastroenterol. Rep."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/s12029-014-9583-1","article-title":"H. pylori Infection, Inflammation and Gastric Cancer","volume":"45","author":"Qadri","year":"2014","journal-title":"J. Gastrointest. Cancer"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1007\/s00018-019-03044-1","article-title":"Helicobacter pylori infection and gastric cancer biology: Tempering a double-edged sword","volume":"76","author":"Mentis","year":"2019","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.3892\/or.2016.5145","article-title":"Pathogenic mechanisms of the oncoprotein CagA in H. pylori-induced gastric cancer","volume":"36","author":"Chen","year":"2016","journal-title":"Oncol. Rep."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s12029-020-00518-5","article-title":"Molecular Mechanism of Helicobacter pylori-Induced Gastric Cancer","volume":"52","author":"Alipour","year":"2021","journal-title":"J. Gastrointest. Cancer"},{"key":"ref_9","first-page":"6221","article-title":"Molecular mechanism of Helicobacter pylori-induced autophagy in gastric cancer (Review)","volume":"18","author":"Zhang","year":"2019","journal-title":"Oncol. Lett."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1053\/j.gastro.2019.10.019","article-title":"Risk Factors and Incidence of Gastric Cancer After Detection of Helicobacter pylori Infection: A Large Cohort Study","volume":"158","author":"Kumar","year":"2020","journal-title":"Gastroenterology"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Machlowska, J., Baj, J., Sitarz, M., Maciejewski, R., and Sitarz, R. (2020). Gastric Cancer: Epidemiology, Risk Factors, Classification, Genomic Characteristics and Treatment Strategies. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21114012"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1080\/01635581.2020.1756353","article-title":"Nutritional Factors Involved in the Etiology of Gastric Cancer: A Systematic Review","volume":"73","author":"Vahid","year":"2021","journal-title":"Nutr. Cancer"},{"key":"ref_13","unstructured":"Weiss, J., Zakas, A., and Hause, J. (2020). Handbook of Clinical Adult Genetics and Genomics: A Practice-Based Approach, Elsevier."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1007\/s00595-015-1283-3","article-title":"Hereditary gastrointestinal cancer","volume":"46","author":"Hata","year":"2016","journal-title":"Surg. Today"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.prp.2015.06.003","article-title":"Hereditary diffuse gastric cancer\u2014An overview","volume":"211","author":"Gurzu","year":"2015","journal-title":"Pathol. Res. Pract."},{"key":"ref_16","first-page":"S9","article-title":"Hereditary gastrointestinal cancer syndromes","volume":"4","author":"Lynch","year":"2011","journal-title":"Gastrointest. Cancer Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"153","DOI":"10.4251\/wjgo.v7.i9.153","article-title":"Hereditary diffuse gastric cancer: What the clinician should know","volume":"7","author":"Tan","year":"2015","journal-title":"World J. Gastrointest. Oncol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1001\/jamasurg.2020.6155","article-title":"Hereditary Diffuse Gastric Cancer Syndrome and the Role of CDH1: A Review","volume":"156","author":"Gamble","year":"2021","journal-title":"JAMA Surg."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1002\/path.4152","article-title":"An \u03b1-E-catenin (CTNNA1) mutation in hereditary diffuse gastric cancer","volume":"229","author":"Majewski","year":"2013","journal-title":"J. Pathol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"101820","DOI":"10.1016\/j.clinre.2021.101820","article-title":"Hereditary diffuse gastric cancer (HDGC). An overview","volume":"46","year":"2022","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s10689-015-9778-z","article-title":"Exome sequencing reveals three novel candidate predisposition genes for diffuse gastric cancer","volume":"14","author":"Donner","year":"2015","journal-title":"Fam. Cancer"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S2468-1253(18)30079-7","article-title":"Germline pathogenic variants in PALB2 and other cancer-predisposing genes in families with hereditary diffuse gastric cancer without CDH1 mutation: A whole-exome sequencing study","volume":"3","author":"Fewings","year":"2018","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.ajhg.2016.03.001","article-title":"Point Mutations in Exon 1B of APC Reveal Gastric Adenocarcinoma and Proximal Polyposis of the Stomach as a Familial Adenomatous Polyposis Variant","volume":"98","author":"Li","year":"2016","journal-title":"Am. J. Hum. Genet."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s10689-019-00127-7","article-title":"Hereditary gastric cancer: What\u2019s new? Update 2013\u20132018","volume":"18","author":"Oliveira","year":"2019","journal-title":"Fam. Cancer"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/ags3.12218","article-title":"Re-emerging role of macroscopic appearance in treatment strategy for gastric cancer","volume":"3","author":"Hosoda","year":"2019","journal-title":"Ann. Gastroenterol. Surg."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10120-018-0868-0","article-title":"Consensus on the pathological definition and classification of poorly cohesive gastric carcinoma","volume":"22","author":"Mariette","year":"2019","journal-title":"Gastric Cancer"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/his.13975","article-title":"The 2019 WHO classification of tumours of the digestive system","volume":"76","author":"Nagtegaal","year":"2020","journal-title":"Histopathology"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s12253-015-9996-6","article-title":"Clinicopathological Variation of Lauren Classification in Gastric Cancer","volume":"22","author":"Chen","year":"2016","journal-title":"Pathol. Oncol. Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/den.12003","article-title":"Endoscopic resection (endoscopic mucosal resection\/endoscopic submucosal dissection) for early gastric cancer","volume":"25","author":"Gotoda","year":"2013","journal-title":"Dig. Endosc."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.3748\/wjg.v25.i17.2029","article-title":"Recent advances in gastric cancer early diagnosis","volume":"25","author":"Necula","year":"2019","journal-title":"World J. Gastroenterol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.3748\/wjg.14.1149","article-title":"Role of symptoms in diagnosis and outcome of gastric cancer","volume":"14","author":"Maconi","year":"2008","journal-title":"World J. Gastroenterol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"3537","DOI":"10.12659\/MSM.916475","article-title":"Recent Advances in the Surgical Treatment of Advanced Gastric Cancer: A Review","volume":"25","author":"Tan","year":"2019","journal-title":"Med. Sci. Monit."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1097\/MOG.0000000000000577","article-title":"Advances in the treatment of gastric cancer: 2019","volume":"35","author":"Ilson","year":"2019","journal-title":"Curr. Opin. Gastroenterol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S1470-2045(20)30012-7","article-title":"Chemotherapy for resectable microsatellite instability-high gastric cancer?","volume":"21","author":"Lordick","year":"2020","journal-title":"Lancet Oncol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s11912-019-0820-4","article-title":"Updates on Management of Gastric Cancer","volume":"21","author":"Johnston","year":"2019","journal-title":"Curr. Oncol. Rep."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/ags3.12438","article-title":"Essential updates 2019\/2020: Perioperative and surgical management of gastric cancer","volume":"5","author":"Irino","year":"2021","journal-title":"Ann. Gastroenterol. Surg."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/annonc\/mdy502","article-title":"Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with metastatic gastric cancer: A JSMO\u2013ESMO initiative endorsed by CSCO, KSMO, MOS, SSO and TOS","volume":"30","author":"Muro","year":"2019","journal-title":"Ann. Oncol."},{"key":"ref_38","first-page":"CD004064","article-title":"Chemotherapy for advanced gastric cancer","volume":"8","author":"Wagner","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"19481","DOI":"10.1097\/MD.0000000000019481","article-title":"Efficacy and safety of elemene combined with chemotherapy in advanced gastric cancerr: A Meta-analysis","volume":"99","author":"Liu","year":"2020","journal-title":"Medicine"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.cels.2021.10.007","article-title":"The structure of the human cell cycle","volume":"13","author":"Stallaert","year":"2022","journal-title":"Cell Syst."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41580-019-0208-1","article-title":"Membrane and organelle dynamics during cell division","volume":"21","author":"Carlton","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"R141","DOI":"10.1530\/ERC-20-0517","article-title":"Novel insights in cell cycle dysregulation during prostate cancer progression","volume":"28","author":"Venkadakrishnan","year":"2021","journal-title":"Endocr.-Relat. Cancer"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1038\/onc.2009.170","article-title":"Mammalian cell-cycle regulation: Several Cdks, numerous cyclins and diverse compensatory mechanisms","volume":"28","author":"Satyanarayana","year":"2009","journal-title":"Oncogene"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"5220","DOI":"10.1038\/sj.onc.1209615","article-title":"RB and cell cycle progression","volume":"25","author":"Giacinti","year":"2006","journal-title":"Oncogene"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"3079","DOI":"10.1242\/dev.091744","article-title":"Cdks, cyclins and CKIs: Roles beyond cell cycle regulation","volume":"140","author":"Lim","year":"2013","journal-title":"Development"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/S0955-0674(00)00151-4","article-title":"Regulation of G1 cyclin-dependent kinases in the mammalian cell cycle","volume":"12","author":"Ekholm","year":"2000","journal-title":"Curr. Opin. Cell Biol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"E8219","DOI":"10.1073\/pnas.1722446115","article-title":"Control of the Restriction Point by Rb and p21","volume":"115","author":"Moser","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.ccell.2021.03.010","article-title":"Targeting cell-cycle machinery in cancer","volume":"39","author":"Suski","year":"2021","journal-title":"Cancer Cell"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/35106065","article-title":"To cycle or not to cycle: A critical decision in cancer","volume":"1","author":"Malumbres","year":"2001","journal-title":"Nat. Rev. Cancer"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"348","DOI":"10.20892\/j.issn.2095-3941.2017.0033","article-title":"Cell cycle regulation and anticancer drug discovery","volume":"14","author":"Bai","year":"2017","journal-title":"Cancer Biol. Med."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0092-8674(04)00300-9","article-title":"Cyclin C\/Cdk3 Promotes Rb-Dependent G0 Exit","volume":"117","author":"Ren","year":"2004","journal-title":"Cell"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1093\/nar\/gkaa1148","article-title":"Chromatin structure restricts origin utilization when quiescent cells re-enter the cell cycle","volume":"49","author":"Lee","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/nrd4504","article-title":"The history and future of targeting cyclin-dependent kinases in cancer therapy","volume":"14","author":"Asghar","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s13046-016-0433-9","article-title":"Cell cycle checkpoint in cancer: A therapeutically targetable double-edged sword","volume":"35","author":"Visconti","year":"2016","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1080\/15384101.2021.1938813","article-title":"Activation of CDC25A phosphatase is limited by CDK2\/cyclin A-mediated feedback inhibition","volume":"20","author":"Ditano","year":"2021","journal-title":"Cell Cycle"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"eaaz9899","DOI":"10.1126\/sciadv.aaz9899","article-title":"A novel landscape of nuclear human CDK2 substrates revealed by in situ phosphorylation","volume":"6","author":"Chi","year":"2020","journal-title":"Sci. Adv."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Ding, L., Cao, J., Lin, W., Chen, H., Xiong, X., Ao, H., Yu, M., Lin, J., and Cui, Q. (2020). The Roles of Cyclin-Dependent Kinases in Cell-Cycle Progression and Therapeutic Strategies in Human Breast Cancer. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21061960"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"57","DOI":"10.4161\/cc.11.1.18775","article-title":"An integrated view of cyclin E function and regulation","volume":"11","author":"Siu","year":"2012","journal-title":"Cell Cycle"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.devcel.2010.02.013","article-title":"Progressive Activation of CyclinB1-Cdk1 Coordinates Entry to Mitosis","volume":"18","author":"Gavet","year":"2010","journal-title":"Dev. Cell"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1242\/dev.047555","article-title":"Spatial regulation of APCCdh1-induced cyclin B1 degradation maintains G2 arrest in mouse oocytes","volume":"137","author":"Holt","year":"2010","journal-title":"Development"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/nature06046","article-title":"Cdk1 is sufficient to drive the mammalian cell cycle","volume":"448","author":"Cerqueira","year":"2007","journal-title":"Nature"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1091\/mbc.e08-07-0771","article-title":"Fine Tuning the Cell Cycle: Activation of the Cdk1 Inhibitory Phosphorylation Pathway during Mitotic Exit","volume":"20","author":"Potapova","year":"2009","journal-title":"Mol. Biol. Cell"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.bbrc.2021.02.117","article-title":"CDK1 inhibitor controls G2\/M phase transition and reverses DNA damage sensitivity","volume":"550","author":"Sunada","year":"2021","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1016\/j.febslet.2011.05.013","article-title":"Beyond ATM: The protein kinase landscape of the DNA damage response","volume":"585","author":"Bensimon","year":"2011","journal-title":"FEBS Lett."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"4129","DOI":"10.1128\/MCB.21.13.4129-4139.2001","article-title":"ATR-Mediated Checkpoint Pathways Regulate Phosphorylation and Activation of Human Chk1","volume":"21","author":"Zhao","year":"2001","journal-title":"Mol. Cell. Biol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/em.22397","article-title":"Roles of Chk2\/CHEK2 in guarding against environmentally induced DNA damage and replication-stress","volume":"61","author":"Mustofa","year":"2020","journal-title":"Environ. Mol. Mutagen."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"13429","DOI":"10.1038\/s41598-017-12868-5","article-title":"Cdk2 strengthens the intra-S checkpoint and counteracts cell cycle exit induced by DNA damage","volume":"7","author":"Lossaint","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1038\/sj.onc.1208474","article-title":"Induction of p21 by p53 following DNA damage inhibits both Cdk4 and Cdk2 activities","volume":"24","author":"He","year":"2005","journal-title":"Oncogene"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/nrc.2016.138","article-title":"Cell cycle proteins as promising targets in cancer therapy","volume":"17","author":"Otto","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Schmidt, M., Rohe, A., Platzer, C., Najjar, A., Erdmann, F., and Sippl, W. (2017). Regulation of G2\/M Transition by Inhibition of WEE1 and PKMYT1 Kinases. Molecules, 22.","DOI":"10.3390\/molecules22122045"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"R1002","DOI":"10.1016\/j.cub.2015.08.051","article-title":"The Molecular Biology of Spindle Assembly Checkpoint Signaling Dynamics","volume":"25","author":"Musacchio","year":"2015","journal-title":"Curr. Biol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1021\/acs.jmedchem.1c01165","article-title":"Development of the First Covalent Monopolar Spindle Kinase 1 (MPS1\/TTK) Inhibitor","volume":"65","author":"Serafim","year":"2022","journal-title":"J. Med. Chem."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1080\/15384101.2018.1502567","article-title":"Targeting the cell cycle in breast cancer: Towards the next phase","volume":"17","author":"Thu","year":"2018","journal-title":"Cell Cycle"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"108929","DOI":"10.1016\/j.celrep.2021.108929","article-title":"Molecular mechanisms of APC\/C release from spindle assembly checkpoint inhibition by APC\/C SUMOylation","volume":"34","author":"Yatskevich","year":"2021","journal-title":"Cell Rep."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s11523-017-0541-2","article-title":"Inhibiting CDK in Cancer Therapy: Current Evidence and Future Directions","volume":"13","author":"Vijayaraghavan","year":"2018","journal-title":"Target. Oncol."},{"key":"ref_76","first-page":"1913","article-title":"CDK inhibitors in cancer therapy, an overview of recent development","volume":"11","author":"Zhang","year":"2021","journal-title":"Am. J. Cancer Res."},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Ettl, T., Schulz, D., and Bauer, R.J. (2022). The Renaissance of Cyclin Dependent Kinase Inhibitors. Cancers, 14.","DOI":"10.3390\/cancers14020293"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.tcb.2021.07.001","article-title":"Cell cycle on the crossroad of tumorigenesis and cancer therapy","volume":"32","author":"Liu","year":"2022","journal-title":"Trends Cell Biol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1101\/gad.271452.115","article-title":"Initiation of stem cell differentiation involves cell cycle-dependent regulation of developmental genes by Cyclin D","volume":"30","author":"Pauklin","year":"2016","journal-title":"Genes Dev."},{"key":"ref_80","unstructured":"Gao, X., Leone, G.W., and Wang, H. (2020). Advances in Cancer Research, Academic Press."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1007\/s12029-018-0079-2","article-title":"Prognostic Value of Cyclin D1 and CD44 Expression in Gastric Adenocarcinoma","volume":"50","author":"Ibrahim","year":"2019","journal-title":"J. Gastrointest. Cancer"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/s41420-022-01079-1","article-title":"CHREBP suppresses gastric cancer progression via the cyclin D1-Rb-E2F1 pathway","volume":"8","author":"Zhang","year":"2022","journal-title":"Cell Death Discov."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/path.5246","article-title":"RN181 is a tumour suppressor in gastric cancer by regulation of the ERK\/MAPK\u2013cyclin D1\/CDK4 pathway","volume":"248","author":"Wang","year":"2019","journal-title":"J. Pathol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"8544","DOI":"10.1096\/fj.201903217R","article-title":"MiR-129-5p induces cell cycle arrest through modulating HOXC10\/Cyclin D1 to inhibit gastric cancer progression","volume":"34","author":"He","year":"2020","journal-title":"FASEB J."},{"key":"ref_85","first-page":"634","article-title":"Curcumin Promoted miR-34a Expression and Suppressed Proliferation of Gastric Cancer Cells","volume":"34","author":"Sun","year":"2019","journal-title":"Cancer Biother. Radiopharm."},{"key":"ref_86","first-page":"19","article-title":"MicroRNA-623 Targets Cyclin D1 to Inhibit Cell Proliferation and Enhance the Chemosensitivity of Cells to 5-Fluorouracil in Gastric Cancer","volume":"27","author":"Jiang","year":"2018","journal-title":"Oncol. Res. Featur. Preclin. Clin. Cancer Ther."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"3613","DOI":"10.1002\/jcp.27083","article-title":"Leukemia inhibitory factor inhibits the proliferation of gastric cancer by inducing G1-phase arrest","volume":"234","author":"Xu","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1080\/15384047.2019.1679554","article-title":"TRIM58 suppresses the tumor growth in gastric cancer by inactivation of \u03b2-catenin signaling via ubiquitination","volume":"21","author":"Liu","year":"2020","journal-title":"Cancer Biol. Ther."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.2147\/CMAR.S244481","article-title":"Glycyrrhizic Acid Inhibits Proliferation of Gastric Cancer Cells by Inducing Cell Cycle Arrest and Apoptosis","volume":"12","author":"Wang","year":"2020","journal-title":"Cancer Manag. Res."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"152795","DOI":"10.1016\/j.prp.2019.152795","article-title":"Dihydroartemisinin inhibits the growth and invasion of gastric cancer cells by regulating cyclin D1-CDK4-Rb signaling","volume":"216","author":"Fan","year":"2020","journal-title":"Pathol. Res. Pract."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.18632\/aging.102684","article-title":"AURKB promotes gastric cancer progression via activation of CCND1 expression","volume":"12","author":"Nie","year":"2020","journal-title":"Aging"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"e148","DOI":"10.1002\/ctm2.148","article-title":"Pyrotinib combined with CDK4\/6 inhibitor in HER2-positive metastatic gastric cancer: A promising strategy from AVATAR mouse to patients","volume":"10","author":"Chen","year":"2020","journal-title":"Clin. Transl. Med."},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Liu, B., Li, X., Sun, F., Tong, X., Bai, Y., Jin, K., Liu, L., Dai, F., and Li, N. (2020). HP-CagA+ Regulates the Expression of CDK4\/CyclinD1 via reg3 to Change Cell Cycle and Promote Cell Proliferation. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21010224"},{"key":"ref_94","first-page":"4224","article-title":"KLF5 promotes proliferation in gastric cancer via regulating p21 and CDK4","volume":"24","author":"Chen","year":"2020","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"6602","DOI":"10.1111\/jcmm.16664","article-title":"METTL16 promotes cell proliferation by up-regulating cyclin D1 expression in gastric cancer","volume":"25","author":"Wang","year":"2021","journal-title":"J. Cell. Mol. Med."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s00428-008-0594-9","article-title":"Cyclin D1 expression is induced by viral BARF1 and is overexpressed in EBV-associated gastric cancer","volume":"452","author":"Wiech","year":"2008","journal-title":"Virchows Arch."},{"key":"ref_97","first-page":"2739","article-title":"Overexpression of IC53d promotes the proliferation of gastric cancer cells by activating the AKT\/GSK3\u03b2\/cyclin D1 signaling pathway","volume":"41","author":"Lin","year":"2019","journal-title":"Oncol. Rep."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"3304","DOI":"10.1002\/jcb.26491","article-title":"Up-regulated WDR5 promotes gastric cancer formation by induced cyclin D1 expression","volume":"119","author":"Sun","year":"2018","journal-title":"J. Cell. Biochem."},{"key":"ref_99","first-page":"1831","article-title":"Transcription activated p73-modulated cyclin D1 expression leads to doxorubicin resistance in gastric cancer","volume":"15","author":"Ji","year":"2018","journal-title":"Exp. Ther. Med."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1002\/cbf.3361","article-title":"SIX1 is upregulated in gastric cancer and regulates proliferation and invasion by targeting the ERK pathway and promoting epithelial-mesenchymal transition","volume":"36","author":"Xie","year":"2018","journal-title":"Cell Biochem. Funct."},{"key":"ref_101","first-page":"1579","article-title":"Resveratrol inhibits the growth of gastric cancer via the Wnt\/\u03b2-catenin pathway","volume":"16","author":"Dai","year":"2018","journal-title":"Oncol. Lett."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1515\/med-2019-0005","article-title":"METTL3 promotes the proliferation and mobility of gastric cancer cells","volume":"14","author":"Lin","year":"2019","journal-title":"Open Med."},{"key":"ref_103","first-page":"2119","article-title":"Long non-coding RNA LINC00857 promotes gastric cancer cell proliferation and predicts poor patient survival","volume":"16","author":"Pang","year":"2018","journal-title":"Oncol. Lett."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"4030826","DOI":"10.1155\/2020\/4030826","article-title":"Circular RNA hsa_circ_0000467 Promotes the Development of Gastric Cancer by Competitively Binding to MicroRNA miR-326-3p","volume":"2020","author":"Mo","year":"2020","journal-title":"BioMed Res. Int."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1002\/2211-5463.12639","article-title":"CORO1C expression is associated with poor survival rates in gastric cancer and promotes metastasis in vitro","volume":"9","author":"Cheng","year":"2019","journal-title":"FEBS Open Bio"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.12659\/MSM.913087","article-title":"Long Chain Non-Coding RNA (lncRNA) HOTAIR Knockdown Increases miR-454-3p to Suppress Gastric Cancer Growth by Targeting STAT3\/Cyclin D1","volume":"25","author":"Jiang","year":"2019","journal-title":"Med. Sci. Monit."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"666","DOI":"10.3389\/fonc.2019.00666","article-title":"Mechanisms of Resistance to CDK4\/6 Inhibitors: Potential Implications and Biomarkers for Clinical Practice","volume":"9","author":"McCartney","year":"2019","journal-title":"Front. Oncol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1002\/ijc.32020","article-title":"Molecular mechanisms of resistance to CDK4\/6 inhibitors in breast cancer: A review","volume":"145","author":"Pandey","year":"2019","journal-title":"Int. J. Cancer"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.ccell.2020.03.010","article-title":"Mechanisms of Sensitivity and Resistance to CDK4\/6 Inhibition","volume":"37","author":"Malumbres","year":"2020","journal-title":"Cancer Cell"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13045-020-00880-8","article-title":"The application and prospect of CDK4\/6 inhibitors in malignant solid tumors","volume":"13","author":"Du","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1080\/15384047.2018.1480290","article-title":"Double amplifications of CDK4 and MDM2 in a gastric inflammatory myofibroblastic tumor mimicking cancer with local invasion of the spleen and diaphragm","volume":"19","author":"He","year":"2018","journal-title":"Cancer Biol. Ther."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s13577-019-00317-6","article-title":"PAK1 silencing is synthetic lethal with CDK4\/6 inhibition in gastric cancer cells via regulating PDK1 expression","volume":"33","author":"Qian","year":"2020","journal-title":"Hum. Cell"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"102672","DOI":"10.1016\/j.ebiom.2020.102672","article-title":"Orphan nuclear receptor Nurr1 promotes Helicobacter pylori-associated gastric carcinogenesis by directly enhancing CDK4 expression","volume":"53","author":"Shang","year":"2020","journal-title":"eBioMedicine"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"9685","DOI":"10.3892\/mmr.2017.7796","article-title":"Clinical implications of progranulin in gastric cancer and its regulation via a positive feedback loop involving AKT and ERK signaling pathways","volume":"16","author":"Yang","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/s41419-018-0643-5","article-title":"Long noncoding RNA gastric cancer-related lncRNA1 mediates gastric malignancy through miRNA-885-3p and cyclin-dependent kinase 4","volume":"9","author":"Lin","year":"2018","journal-title":"Cell Death Dis."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.cancergencyto.2010.03.013","article-title":"Genetic profiles of gastroesophageal cancer: Combined analysis using expression array and tiling array\u2013comparative genomic hybridization","volume":"200","author":"Johansson","year":"2010","journal-title":"Cancer Genet. Cytogenet."},{"key":"ref_117","first-page":"11692","article-title":"CDK4\/6 inhibitor suppresses gastric cancer with CDKN2A mutation","volume":"8","author":"Huang","year":"2015","journal-title":"Int. J. Clin. Exp. Med."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.3892\/ol.2014.2370","article-title":"miR-449a and CDK6 in gastric carcinoma","volume":"8","author":"Li","year":"2014","journal-title":"Oncol. Lett."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1007\/s12032-011-9823-1","article-title":"miR-107 targets cyclin-dependent kinase 6 expression, induces cell cycle G1 arrest and inhibits invasion in gastric cancer cells","volume":"29","author":"Feng","year":"2012","journal-title":"Med. Oncol."},{"key":"ref_120","first-page":"2473","article-title":"Antiproliferative effects of the CDK6 inhibitor PD0332991 and its effect on signaling networks in gastric cancer cells","volume":"41","author":"Wang","year":"2018","journal-title":"Int. J. Mol. Med."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"e503","DOI":"10.1002\/ctm2.503","article-title":"Oncogenic PAX6 elicits CDK4\/6 inhibitor resistance by epigenetically inactivating the LATS2-Hippo signaling pathway","volume":"11","author":"Zhang","year":"2021","journal-title":"Clin. Transl. Med."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"3145","DOI":"10.7150\/jca.56097","article-title":"CDC37L1 acts as a suppressor of migration and proliferation in gastric cancer by down-regulating CDK6","volume":"12","author":"Li","year":"2021","journal-title":"J. Cancer"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"BSR20181556","DOI":"10.1042\/BSR20181556","article-title":"The tumor-suppressive function of miR-1296-5p by targeting EGFR and CDK6 in gastric cancer","volume":"39","author":"Jia","year":"2019","journal-title":"Biosci. Rep."},{"key":"ref_124","first-page":"3689","article-title":"miRNA-191-5p represses cell growth by targeting CDK6 in gastric cancer","volume":"100","author":"Cao","year":"2020","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"ref_125","first-page":"7920","article-title":"MiR-29c suppresses cell invasion and migration by directly targeting CDK6 in gastric carcinoma","volume":"23","author":"Jiang","year":"2019","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1515\/med-2019-0012","article-title":"Regional hyperthermia combined with chemotherapy in advanced gastric cancer","volume":"14","author":"Fang","year":"2019","journal-title":"Open Med."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"240","DOI":"10.3892\/mmr.2021.11879","article-title":"CDK6 is stimulated by hyperthermia and protects gastric cancer cells from hyperthermia-induced damage","volume":"23","author":"Liu","year":"2021","journal-title":"Mol. Med. Rep."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"6904","DOI":"10.18632\/aging.103050","article-title":"Identification of UAP1L1 as tumor promotor in gastric cancer through regulation of CDK6","volume":"12","author":"Qi","year":"2020","journal-title":"Aging"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/s41419-022-04500-w","article-title":"Linc01133 contributes to gastric cancer growth by enhancing YES1-dependent YAP1 nuclear translocation via sponging miR-145-5p","volume":"13","author":"Sun","year":"2022","journal-title":"Cell Death Dis."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"9096","DOI":"10.1002\/cam4.3497","article-title":"The prognostic value of circRNAs for gastric cancer: A systematic review and meta-analysis","volume":"9","author":"Chen","year":"2020","journal-title":"Cancer Med."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12935-019-0737-x","article-title":"hsa_circ_0081143 promotes cisplatin resistance in gastric cancer by targeting miR-646\/CDK6 pathway","volume":"19","author":"Xue","year":"2019","journal-title":"Cancer Cell Int."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"8197","DOI":"10.2147\/OTT.S193031","article-title":"circZNF609 promotes the proliferation and migration of gastric cancer by sponging miR-483-3p and regulating CDK6","volume":"12","author":"Wu","year":"2019","journal-title":"OncoTargets Ther."},{"key":"ref_133","first-page":"2806","article-title":"Circular RNA circ_ASAP2 promotes cell viability, migration, and invasion of gastric cancer cells by regulating the miR-770-5p\/CDK6 axis","volume":"13","author":"Chen","year":"2020","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"ref_134","first-page":"666","article-title":"LncRNA LINC00974 Upregulates CDK6 to Promote Cell Cycle Progression in Gastric Carcinoma","volume":"34","author":"Gao","year":"2019","journal-title":"Cancer Biother. Radiopharm."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1158\/1078-0432.CCR-04-1730","article-title":"Combined Evaluation of Expressions of Cyclin E and p53 Proteins as Prognostic Factors for Patients with Gastric Cancer","volume":"11","author":"Almasri","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/j.1349-7006.1995.tb02442.x","article-title":"Frequent Amplification of the Cyclin E Gene in Human Gastric Carcinomas","volume":"86","author":"Akama","year":"1995","journal-title":"Jpn. J. Cancer Res."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1093\/annonc\/mdu535","article-title":"Cyclin E amplification\/overexpression is associated with poor prognosis in gastric cancer","volume":"26","author":"Alsina","year":"2015","journal-title":"Ann. Oncol."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"BSR20190381","DOI":"10.1042\/BSR20190381","article-title":"Down-regulation of CCNE1 expression suppresses cell proliferation and sensitizes gastric carcinoma cells to Cisplatin","volume":"39","author":"Zhang","year":"2019","journal-title":"Biosci. Rep."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"199","DOI":"10.2739\/kurumemedj.47.199","article-title":"Immunohistochemical Study on the Expression of Cyclin D1 and E in Gastric Cancer","volume":"47","author":"Aoyagi","year":"2000","journal-title":"Kurume Med. J."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"513","DOI":"10.3346\/jkms.1998.13.5.513","article-title":"Expression of cyclin D1 and cyclin E in human gastric carcinoma and its clinicopathologic significance","volume":"13","author":"Ahn","year":"1998","journal-title":"J. Korean Med. Sci."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"3809","DOI":"10.11569\/wcjd.v15.i36.3809","article-title":"Expression of P27 and cyclin D1 and E expression in gastric cancer","volume":"15","author":"Zhang","year":"2007","journal-title":"World Chin. J. Dig."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s101200050011","article-title":"Role of cyclin E and p53 expression in progression of early gastric cancer","volume":"1","author":"Jiaqing","year":"1998","journal-title":"Gastric Cancer"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1053\/ejso.1998.0619","article-title":"Expression of cell-cycle regulators, cyclin E and p21WAF1\/CIP1, potential prognostic markers for gastric cancer","volume":"25","author":"Jang","year":"1999","journal-title":"Eur. J. Surg. Oncol. (EJSO)"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1006\/jsre.2000.5998","article-title":"Expression of Cell-Cycle Regulators p27 and Cyclin E Correlates with Survival in Gastric Carcinoma Patients","volume":"94","author":"So","year":"2000","journal-title":"J. Surg. Res."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1136\/jcp.2006.042648","article-title":"Cyclin E low molecular weight isoforms occur commonly in early-onset gastric cancer and independently predict survival","volume":"61","author":"Milne","year":"2008","journal-title":"J. Clin. Pathol."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s12032-016-0754-8","article-title":"Cyclin D1 and cyclin E2 are differentially expressed in gastric cancer","volume":"33","author":"Kumari","year":"2016","journal-title":"Med. Oncol."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1007\/s10620-008-0464-y","article-title":"Does the Expression of Cyclin E, pRb, and p21 Correlate with Prognosis in Gastric Adenocarcinoma?","volume":"54","author":"Kouraklis","year":"2009","journal-title":"Dig. Dis. Sci."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1177\/1533034614568098","article-title":"Prognostic Value of Expression of Cyclin E in Gastrointestinal Cancer: A Systematic Review and Meta-Analysis","volume":"15","author":"Huang","year":"2016","journal-title":"Technol. Cancer Res. Treat."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"152434","DOI":"10.1016\/j.prp.2019.152434","article-title":"CCNE1 amplification is associated with liver metastasis in gastric carcinoma","volume":"215","author":"Kim","year":"2019","journal-title":"Pathol. Res. Pract."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3748\/wjg.v8.i1.60","article-title":"Overexpression of cyclin E in Mongolian gerbil with Helicobacter pylori-induced gastric precancerosis","volume":"8","author":"Yao","year":"2002","journal-title":"World J. Gastroenterol."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.canlet.2018.04.037","article-title":"Cyclin E overexpression confers resistance to the CDK4\/6 specific inhibitor palbociclib in gastric cancer cells","volume":"430","author":"Min","year":"2018","journal-title":"Cancer Lett."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"21020","DOI":"10.1200\/jco.2007.25.18_suppl.21020","article-title":"Preferential chemosensitivity to gemcitabine by cyclin E overexpression in human gastric cancers","volume":"25","author":"Yeh","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"774845","DOI":"10.3389\/fcell.2021.774845","article-title":"Cyclin E\/CDK2: DNA Replication, Replication Stress and Genomic Instability","volume":"9","author":"Fagundes","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.bbrc.2018.01.046","article-title":"Upregulation of CDCA5 promotes gastric cancer malignant progression via influencing cyclin E1","volume":"496","author":"Zhang","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"192","DOI":"10.15430\/JCP.2019.24.3.192","article-title":"\u03b2-carotene Inhibits Expression of c-Myc and Cyclin E in Helicobacter pylori-infected Gastric Epithelial Cells","volume":"24","author":"Kim","year":"2019","journal-title":"J. Cancer Prev."},{"key":"ref_156","first-page":"3375","article-title":"Knockdown of long noncoding RNA GHET1 inhibits cell-cycle progression and invasion of gastric cancer cells","volume":"18","author":"Xia","year":"2018","journal-title":"Mol. Med. Rep."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.bbrc.2010.02.083","article-title":"Ribosomal protein L6 promotes growth and cell cycle progression through upregulating cyclin E in gastric cancer cells","volume":"393","author":"Gou","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_158","first-page":"44","article-title":"Analysis of cyclin E co-expression genes reveals nuclear transcription factor Y subunit alpha is an oncogene in gastric cancer","volume":"5","author":"Bie","year":"2019","journal-title":"Chronic Dis. Transl. Med."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"3145","DOI":"10.3892\/mmr.2014.2605","article-title":"14-3-3\u025b functions as an oncogene in SGC7901 gastric cancer cells through involvement of cyclin E and p27kip1","volume":"10","author":"Gong","year":"2014","journal-title":"Mol. Med. Rep."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1600-0463.2009.02579.x","article-title":"Enhancer of zeste homolog 2 expression is associated with tumor cell proliferation and metastasis in gastric cancer","volume":"118","author":"Choi","year":"2010","journal-title":"Apmis"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"584960","DOI":"10.3389\/fphar.2020.584960","article-title":"Bruceine D inhibits Cell Proliferation Through Downregulating LINC01667\/MicroRNA-138-5p\/Cyclin E1 Axis in Gastric Cancer","volume":"11","author":"Li","year":"2020","journal-title":"Front. Pharmacol."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1007\/s00018-002-8510-y","article-title":"Cyclin A in cell cycle control and cancer","volume":"59","author":"Yam","year":"2002","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.semcdb.2005.02.007","article-title":"New insights into cyclins, CDKs, and cell cycle control","volume":"16","author":"Sanchez","year":"2005","journal-title":"Semin. Cell Dev. Biol."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1002\/ijc.21944","article-title":"Prognostic significance of cyclin A in gastric cancer","volume":"119","author":"Mrena","year":"2006","journal-title":"Int. J. Cancer"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.drudis.2019.12.001","article-title":"Targeting CDK2 in cancer: Challenges and opportunities for therapy","volume":"25","author":"Tadesse","year":"2020","journal-title":"Drug Discov. Today"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"104","DOI":"10.7150\/thno.30308","article-title":"Selective Autophagy Regulates Cell Cycle in Cancer Therapy","volume":"9","author":"Zheng","year":"2019","journal-title":"Theranostics"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1002\/stem.620","article-title":"An Important Role for CDK2 in G1 to S Checkpoint Activation and DNA Damage Response in Human Embryonic Stem Cells","volume":"29","author":"Neganova","year":"2011","journal-title":"STEM CELLS"},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.omtn.2021.01.025","article-title":"Silencing LINC01021 inhibits gastric cancer through upregulation of KISS1 expression by blocking CDK2-dependent phosphorylation of CDX2","volume":"24","author":"Wang","year":"2021","journal-title":"Mol. Ther.\u2014Nucleic Acids"},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1002\/2211-5463.12408","article-title":"Poly(rC) binding protein 2 (PCBP2) promotes the viability of human gastric cancer cells by regulating CDK2","volume":"8","author":"Chen","year":"2018","journal-title":"FEBS Open Bio"},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.bbrc.2018.10.060","article-title":"DDX21 promotes gastric cancer proliferation by regulating cell cycle","volume":"505","author":"Cao","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1111\/cas.13691","article-title":"CDK2 positively regulates aerobic glycolysis by suppressing SIRT5 in gastric cancer","volume":"109","author":"Tang","year":"2018","journal-title":"Cancer Sci."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"5877","DOI":"10.1158\/0008-5472.CAN-18-1011","article-title":"EGR1-Mediated Transcription of lncRNA-HNF1A-AS1 Promotes Cell-Cycle Progression in Gastric Cancer","volume":"78","author":"Liu","year":"2018","journal-title":"Cancer Res"},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1038\/s41598-021-81815-2","article-title":"Sulforaphane induces S-phase arrest and apoptosis via p53-dependent manner in gastric cancer cells","volume":"11","author":"Wang","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1038\/sj.onc.1204203","article-title":"Caspase-mediated Cdk2 activation is a critical step to execute transforming growth factor-\u03b21-induced apoptosis in human gastric cancer cells","volume":"20","author":"Kim","year":"2001","journal-title":"Oncogene"},{"key":"ref_175","first-page":"2839","article-title":"MICRORNA-638 INHIBITED CELL PROLIFERATION BY TARGETING CDK2","volume":"36","author":"Li","year":"2020","journal-title":"Acta Medica Mediterr."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1002\/cam4.818","article-title":"miR-302b regulates cell cycles by targeting CDK 2 via ERK signaling pathway in gastric cancer","volume":"5","author":"Liu","year":"2016","journal-title":"Cancer Med."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1093\/nar\/gkr934","article-title":"Upregulation of Cyclin B1 by miRNA and its implications in cancer","volume":"40","author":"Huang","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"694","DOI":"10.3349\/ymj.2007.48.4.694","article-title":"Prognostic Implications of Cyclin B1, p34cdc2, p27Kip1and p53 Expression in Gastric Cancer","volume":"48","author":"Kim","year":"2007","journal-title":"Yonsei Med. J."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/s00432-002-0359-9","article-title":"Overexpression of cyclin B1 in gastric cancer and its clinicopathological significance: An immunohistological study","volume":"128","author":"Yasuda","year":"2002","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"6673","DOI":"10.2147\/OTT.S171716","article-title":"Clinical significance and biological roles of cyclins in gastric cancer","volume":"11","author":"Zhang","year":"2018","journal-title":"OncoTargets Ther."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/j.humpath.2010.01.007","article-title":"Evaluation of cell cycle protein expression in gastric cancer: Cyclin B1 expression and its prognostic implication","volume":"41","author":"Begnami","year":"2010","journal-title":"Hum. Pathol."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.canlet.2018.11.019","article-title":"Cyclin B1\/CDK1-regulated mitochondrial bioenergetics in cell cycle progression and tumor resistance","volume":"443","author":"Xie","year":"2019","journal-title":"Cancer Lett."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1038\/s41419-018-1211-8","article-title":"CREPT\/RPRD1B associates with Aurora B to regulate Cyclin B1 expression for accelerating the G2\/M transition in gastric cancer","volume":"9","author":"Ding","year":"2018","journal-title":"Cell Death Dis."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1002\/ijc.24588","article-title":"Downregulation of P21-Activated Kinase-1 Inhibits the Growth of Gastric Cancer Cells Involving Cyclin B1","volume":"125","author":"Liu","year":"2009","journal-title":"Int. J. Cancer"},{"key":"ref_185","first-page":"105","article-title":"Tumor-suppressive mir-663 gene induces mitotic catastrophe growth arrest in human gastric cancer cells","volume":"24","author":"Pan","year":"2010","journal-title":"Oncol. Rep."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s10020-021-00302-6","article-title":"Phosphorylation of islet-1 serine 269 by CDK1 increases its transcriptional activity and promotes cell proliferation in gastric cancer","volume":"27","author":"Shi","year":"2021","journal-title":"Mol. Med."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"758","DOI":"10.2174\/1871520620666200203125712","article-title":"CDK1 in Breast Cancer: Implications for Theranostic Potential","volume":"20","author":"Izadi","year":"2020","journal-title":"Anti-Cancer Agents Med. Chem."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"620164","DOI":"10.3389\/fcell.2020.620164","article-title":"Analysis of Cyclin-Dependent Kinase 1 as an Independent Prognostic Factor for Gastric Cancer Based on Statistical Methods","volume":"8","author":"Zhang","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1002\/mc.23343","article-title":"Hyperactivation of MEK\/ERK pathway by Ca 2+\/calmodulin-dependent protein kinase kinase 2 promotes cellular proliferation by activating cyclin-dependent kinases and minichromosome maintenance protein in gastric cancer cells","volume":"60","author":"Najar","year":"2021","journal-title":"Mol. Carcinog."},{"key":"ref_190","doi-asserted-by":"crossref","unstructured":"Lin, L.-L., Huang, H.-C., and Juan, H.-F. (2012). Revealing the Molecular Mechanism of Gastric Cancer Marker Annexin A4 in Cancer Cell Proliferation Using Exon Arrays. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0044615"},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1080\/15384101.2018.1502574","article-title":"LncRNA CASC11 promoted gastric cancer cell proliferation, migration and invasion in vitro by regulating cell cycle pathway","volume":"17","author":"Zhang","year":"2018","journal-title":"Cell Cycle"},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.7150\/ijbs.57623","article-title":"ESRRA promotes gastric cancer development by regulating the CDC25C\/CDK1\/CyclinB1 pathway via DSN1","volume":"17","author":"Li","year":"2021","journal-title":"Int. J. Biol. Sci."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"100935","DOI":"10.1016\/j.jbc.2021.100935","article-title":"Molecular basis for RASSF10\/NPM\/RNF2 feedback cascade\u2013mediated regulation of gastric cancer cell proliferation","volume":"297","author":"Sivagnanam","year":"2021","journal-title":"J. Biol. Chem."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/s41419-022-05254-1","article-title":"Circ_CEA promotes the interaction between the p53 and cyclin-dependent kinases 1 as a scaffold to inhibit the apoptosis of gastric cancer","volume":"13","author":"Yuan","year":"2022","journal-title":"Cell Death Dis."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/onc.2015.80","article-title":"Activation of nuclear PTEN by inhibition of Notch signaling induces G2\/M cell cycle arrest in gastric cancer","volume":"35","author":"Kim","year":"2016","journal-title":"Oncogene"},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"e923664","DOI":"10.12659\/MSM.923664","article-title":"Cyclin-Dependent Kinase 1 (CDK1) is Co-Expressed with CDCA5: Their Functions in Gastric Cancer Cell Line MGC-803","volume":"26","author":"Huang","year":"2020","journal-title":"Med. Sci. Monit."},{"key":"ref_197","first-page":"663","article-title":"Histone deacetylase 3 inhibits new tumor suppressor gene DTWD1 in gastric cancer","volume":"5","author":"Ma","year":"2015","journal-title":"Am. J. Cancer Res."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"214","DOI":"10.3390\/futurepharmacol2030015","article-title":"Therapeutic Potential of Mitotic Kinases\u2019 Inhibitors in Cancers of the Gastrointestinal System","volume":"2","author":"Javed","year":"2022","journal-title":"Futur. Pharmacol."},{"key":"ref_199","first-page":"515901","article-title":"Flavonoids Isolated from Korea Citrus aurantium L. Induce G2\/M Phase Arrest and Apoptosis in Human Gastric Cancer AGS Cells","volume":"2012","author":"Lee","year":"2012","journal-title":"Evid.-Based Complement. Altern. Med."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"868","DOI":"10.3892\/or.2014.3662","article-title":"Kaempferol inhibits gastric cancer tumor growth: An in vitro and in vivo study","volume":"33","author":"Song","year":"2015","journal-title":"Oncol. Rep."},{"key":"ref_201","doi-asserted-by":"crossref","unstructured":"Sankaranarayanan, R., Valiveti, C.K., Kumar, D.R., Van Slambrouck, S., Kesharwani, S.S., Seefeldt, T., Scaria, J., Tummala, H., and Bhat, G.J. (2019). The Flavonoid Metabolite 2,4,6-Trihydroxybenzoic Acid Is a CDK Inhibitor and an Anti-Proliferative Agent: A Potential Role in Cancer Prevention. Cancers, 11.","DOI":"10.3390\/cancers11030427"},{"key":"ref_202","first-page":"5246","article-title":"Menadione induces G2\/M arrest in gastric cancer cells by down-regulation of CDC25C and proteasome mediated degradation of CDK1 and cyclin B1","volume":"8","author":"Lee","year":"2016","journal-title":"Am. J. Transl. Res."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s11010-008-9749-x","article-title":"Anti-proliferative and chemosensitizing effects of luteolin on human gastric cancer AGS cell line","volume":"313","author":"Wu","year":"2008","journal-title":"Mol. Cell. Biochem."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"779","DOI":"10.2147\/OTT.S45865","article-title":"Apoptosis and G2\/M arrest induced by Allium ursinum (ramson) watery extract in an AGS gastric cancer cell line","volume":"6","author":"Xu","year":"2013","journal-title":"OncoTargets Ther."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"6437","DOI":"10.7314\/APJCP.2014.15.15.6437","article-title":"Downregulation of Cdk1 and CyclinB1 Expression Contributes to Oridonin-induced Cell Cycle Arrest at G2\/M Phase and Growth Inhibition in SGC-7901 Gastric Cancer Cells","volume":"15","author":"Gao","year":"2014","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.canlet.2010.12.016","article-title":"Licochalcone A inhibits growth of gastric cancer cells by arresting cell cycle progression and inducing apoptosis","volume":"302","author":"Xiao","year":"2011","journal-title":"Cancer Lett."},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"6791","DOI":"10.7314\/APJCP.2014.15.16.6791","article-title":"Silibinin Inhibits Proliferation, Induces Apoptosis and Causes Cell Cycle Arrest in Human Gastric Cancer MGC803 Cells Via STAT3 Pathway Inhibition","volume":"15","author":"Wang","year":"2014","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"ref_208","first-page":"1605","article-title":"Resveratrol synergizes with cisplatin in antineoplastic effects against AGS gastric cancer cells by inducing endoplasmic reticulum stress-mediated apoptosis and G2\/M phase arrest","volume":"44","author":"Ren","year":"2020","journal-title":"Oncol. Rep."},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.2147\/OTT.S239336","article-title":"A Review of Research Progress in Multidrug-Resistance Mechanisms in Gastric Cancer","volume":"13","author":"Ruan","year":"2020","journal-title":"OncoTargets Ther."},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"e770","DOI":"10.1002\/ctm2.770","article-title":"Ubiquitylation of cyclin C by HACE1 regulates cisplatin-associated sensitivity in gastric cancer","volume":"12","author":"Jiang","year":"2022","journal-title":"Clin. Transl. Med."},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"e833","DOI":"10.1002\/ctm2.833","article-title":"Cyclin C: A new responser for chemosensitivity in cancer","volume":"12","author":"Fang","year":"2022","journal-title":"Clin. Transl. Med."},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jss.2008.06.020","article-title":"Expression Levels of Cyclin G2, But Not Cyclin E, Correlate with Gastric Cancer Progression","volume":"157","author":"Choi","year":"2009","journal-title":"J. Surg. Res."},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1186\/s13046-018-0973-2","article-title":"Cyclin G2 suppresses Wnt\/\u03b2-catenin signaling and inhibits gastric cancer cell growth and migration through Dapper1","volume":"37","author":"Gao","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.3892\/or.2016.4876","article-title":"MicroRNA-340 promotes the tumor growth of human gastric cancer by inhibiting cyclin G2","volume":"36","author":"Yin","year":"2016","journal-title":"Oncol. Rep."},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"14618","DOI":"10.5897\/AJB11.890","article-title":"Mutation analysis of the negative regulator cyclin G2 in gastric cancer","volume":"10","author":"Gao","year":"2011","journal-title":"Afr. J. Biotechnol."},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.cell.2015.08.063","article-title":"CDK7-Dependent Transcriptional Addiction in Triple-Negative Breast Cancer","volume":"163","author":"Wang","year":"2015","journal-title":"Cell"},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"26739","DOI":"10.1073\/pnas.2010885117","article-title":"Structural basis for CDK7 activation by MAT1 and Cyclin H","volume":"117","author":"Peissert","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_218","first-page":"3664","article-title":"Cyclin-dependent kinase 7 inhibitor THZ2 inhibits the growth of human gastric cancer in vitro and in vivo","volume":"10","author":"Huang","year":"2018","journal-title":"Am. J. Transl. Res."},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.7314\/APJCP.2012.13.4.1425","article-title":"Overexpression of Cyclin L2 Inhibits Growth and Enhances Chemosensitivity in Human Gastric Cancer Cells","volume":"13","author":"Li","year":"2012","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1097\/CAD.0000000000000915","article-title":"MicroRNA-216b regulates cell proliferation, invasion and cycle progression via interaction with cyclin T2 in gastric cancer","volume":"31","author":"Chen","year":"2020","journal-title":"Anti-Cancer Drugs"},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"655479","DOI":"10.3389\/fonc.2021.655479","article-title":"CDK10 in Gastrointestinal Cancers: Dual Roles as a Tumor Suppressor and Oncogene","volume":"11","author":"Bazzi","year":"2021","journal-title":"Front. Oncol."},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"188716","DOI":"10.1016\/j.bbcan.2022.188716","article-title":"Cyclin-dependent kinases in DNA damage response","volume":"1877","author":"Kciuk","year":"2022","journal-title":"Biochim. Biophys. Acta (BBA) Rev. Cancer"},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.3748\/wjg.v23.i11.2012","article-title":"Expression of CRM1 and CDK5 shows high prognostic accuracy for gastric cancer","volume":"23","author":"Sun","year":"2017","journal-title":"World J. Gastroenterol."},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1158\/1078-0432.CCR-14-1950","article-title":"Cyclin-Dependent Kinase 5 Decreases in Gastric Cancer and Its Nuclear Accumulation Suppresses Gastric Tumorigenesis","volume":"21","author":"Cao","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"ref_225","first-page":"779","article-title":"CDK5 suppresses the metastasis of gastric cancer cells by interacting with and regulating PP2A","volume":"41","author":"Lu","year":"2019","journal-title":"Oncol. Rep."},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.2147\/DDDT.S86317","article-title":"Selective CDK7 inhibition with BS-181 suppresses cell proliferation and induces cell cycle arrest and apoptosis in gastric cancer","volume":"10","author":"Wang","year":"2016","journal-title":"Drug Des. Dev. Ther."},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1002\/iub.1543","article-title":"Upregulation of cyclin-dependent kinase 7 and matrix metalloproteinase-14 expression contribute to metastatic properties of gastric cancer","volume":"68","author":"Naseh","year":"2016","journal-title":"IUBMB Life"},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/s13000-014-0164-1","article-title":"MicroRNA-107 promotes proliferation of gastric cancer cells by targeting cyclin dependent kinase 8","volume":"9","author":"Song","year":"2014","journal-title":"Diagn. Pathol."},{"key":"ref_229","first-page":"1375","article-title":"Roles of cyclin-dependent kinase 8 and?-catenin in the oncogenesis and progression of gastric adenocarcinoma","volume":"38","author":"Kim","year":"2011","journal-title":"Int. J. Oncol."},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1080\/21691401.2017.1351983","article-title":"MicroRNA-613 inhibits the progression of gastric cancer by targeting CDK9","volume":"46","author":"Lu","year":"2018","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"ref_231","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.7150\/jca.20142","article-title":"Low Expression of CDK10 Correlates with Adverse Prognosis in Gastric Carcinoma","volume":"8","author":"Zhao","year":"2017","journal-title":"J. Cancer"},{"key":"ref_232","first-page":"6812","article-title":"Downregulated CDK10 expression in gastric cancer: Association with tumor progression and poor prognosis","volume":"17","author":"You","year":"2018","journal-title":"Mol. Med. Rep."},{"key":"ref_233","doi-asserted-by":"crossref","first-page":"152962","DOI":"10.1016\/j.prp.2020.152962","article-title":"Low expression of CDK12 in gastric cancer is correlated with advanced stage and poor outcome","volume":"216","author":"Liu","year":"2020","journal-title":"Pathol. Res. Pract."},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"6201","DOI":"10.7150\/thno.46137","article-title":"CDK12 and PAK2 as novel therapeutic targets for human gastric cancer","volume":"10","author":"Liu","year":"2020","journal-title":"Theranostics"},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"707295","DOI":"10.3389\/fmolb.2021.707295","article-title":"CDK13-Mediated Cell Cycle Disorder Promotes Tumorigenesis of High HMGA2 Expression Gastric Cancer","volume":"8","author":"Wu","year":"2021","journal-title":"Front. Mol. Biosci."},{"key":"ref_236","doi-asserted-by":"crossref","unstructured":"Yang, L., Zhu, J., Huang, H., Yang, Q., Cai, J., Wang, Q., Zhu, J., Shao, M., Xiao, J., and Cao, J. (2015). PFTK1 Promotes Gastric Cancer Progression by Regulating Proliferation, Migration and Invasion. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0140451"},{"key":"ref_237","doi-asserted-by":"crossref","first-page":"10151","DOI":"10.1111\/jcmm.15625","article-title":"CXXC finger protein 4 inhibits the CDK18-ERK1\/2 axis to suppress the immune escape of gastric cancer cells with involvement of ELK1\/MIR100HG pathway","volume":"24","author":"Li","year":"2020","journal-title":"J. Cell. Mol. Med."},{"key":"ref_238","first-page":"11602","article-title":"ISOC1 promotes the proliferation of gastric cancer cells by positively regulating CDK19","volume":"24","author":"Zhao","year":"2020","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_239","doi-asserted-by":"crossref","unstructured":"Lee, Y., Lee, C.E., Oh, S., Kim, H., Lee, J., Kim, S.B., and Kim, H.S. (2020). Pharmacogenomic Analysis Reveals CCNA2 as a Predictive Biomarker of Sensitivity to Polo-Like Kinase I Inhibitor in Gastric Cancer. Cancers, 12.","DOI":"10.3390\/cancers12061418"},{"key":"ref_240","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1038\/s41598-020-79235-9","article-title":"Identifying of biomarkers associated with gastric cancer based on 11 topological analysis methods of CytoHubba","volume":"11","author":"Ma","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_241","doi-asserted-by":"crossref","first-page":"4517","DOI":"10.3892\/ol.2017.6736","article-title":"Cyclin D1 overexpression correlates with poor tumor differentiation and prognosis in gastric cancer","volume":"14","author":"Shan","year":"2017","journal-title":"Oncol. Lett."},{"key":"ref_242","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.humpath.2003.07.005","article-title":"Abnormal expression of pRb, p16, and cyclin D1 in gastric adenocarcinoma and its lymph node metastases: Relationship with pathological features and survival","volume":"34","author":"Feakins","year":"2003","journal-title":"Hum. Pathol."},{"key":"ref_243","first-page":"405","article-title":"A study on the prognostic value of cyclins D1 and E expression levels in resectable gastric cancer and on some correlations between cyclins expression, histoclinical parameters and selected protein products of cell-cycle regulatory genes","volume":"24","author":"Tenderenda","year":"2005","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_244","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S0002-9440(10)64763-3","article-title":"Cyclin D2 Overexpression and Lack of p27 Correlate Positively and Cyclin E Inversely with a Poor Prognosis in Gastric Cancer Cases","volume":"156","author":"Takano","year":"2000","journal-title":"Am. J. Pathol."},{"key":"ref_245","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/(SICI)1096-9896(199910)189:2<194::AID-PATH426>3.0.CO;2-P","article-title":"Cyclin D2, but not cyclin D1, overexpression closely correlates with gastric cancer progression and prognosis","volume":"189","author":"Takano","year":"1999","journal-title":"J. Pathol."},{"key":"ref_246","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1002\/(SICI)1097-0142(19980401)82:7<1238::AID-CNCR5>3.0.CO;2-B","article-title":"Prognostic value of cyclin E and p53 expression in gastric carcinoma","volume":"82","author":"Sakaguchi","year":"1998","journal-title":"Cancer"},{"key":"ref_247","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1002\/1097-0142(20000915)89:6<1214::AID-CNCR4>3.0.CO;2-0","article-title":"The cooperative role of p27 with cyclin E in the prognosis of advanced gastric carcinoma","volume":"89","author":"Xiangming","year":"2000","journal-title":"Cancer"},{"key":"ref_248","first-page":"5693","article-title":"Cyclin-dependent kinase 1 gene expression is associated with poor prognosis in gastric carcinoma","volume":"9","author":"Masuda","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"ref_249","doi-asserted-by":"crossref","unstructured":"Ihle, M.A., Huss, S., Jeske, W., Hartmann, W., Merkelbach-Bruse, S., Schildhaus, H.-U., B\u00fcttner, R., Sihto, H., Hall, K.S., and Eriksson, M. (2018). Expression of cell cycle regulators and frequency of TP53 mutations in high risk gastrointestinal stromal tumors prior to adjuvant imatinib treatment. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0193048"},{"key":"ref_250","doi-asserted-by":"crossref","first-page":"8777","DOI":"10.12659\/MSM.916902","article-title":"Identification of Potentially Functional CircRNA-miRNA-mRNA Regulatory Network in Gastric Carcinoma using Bioinformatics Analysis","volume":"25","author":"Yang","year":"2019","journal-title":"Med. Sci. Monit."},{"key":"ref_251","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.yexmp.2016.05.001","article-title":"Upregulation of CDK7 in gastric cancer cell promotes tumor cell proliferation and predicts poor prognosis","volume":"100","author":"Wang","year":"2016","journal-title":"Exp. Mol. Pathol."},{"key":"ref_252","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.7150\/ijms.34541","article-title":"Expression pattern of CDK12 protein in gastric cancer and its positive correlation with CD8+ cell density and CCL12 expression","volume":"16","author":"Ji","year":"2019","journal-title":"Int. J. Med. Sci."},{"key":"ref_253","doi-asserted-by":"crossref","first-page":"10477","DOI":"10.2147\/CMAR.S208818","article-title":"CDH1 (E-Cadherin) Mutation and Gastric Cancer: Genetics, Molecular Mechanisms and Guidelines for Management","volume":"11","author":"Shenoy","year":"2019","journal-title":"Cancer Manag. Res."},{"key":"ref_254","doi-asserted-by":"crossref","first-page":"3449","DOI":"10.1007\/s10620-010-1206-5","article-title":"Association Between Cyclin D1 Polymorphism with CpG Island Promoter Methylation Status of Tumor Suppressor Genes in Gastric Cancer","volume":"55","author":"Tahara","year":"2010","journal-title":"Dig. Dis. Sci."},{"key":"ref_255","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.canlet.2017.03.038","article-title":"Targeting KDM1A attenuates Wnt\/\u03b2-catenin signaling pathway to eliminate sorafenib-resistant stem-like cells in hepatocellular carcinoma","volume":"398","author":"Huang","year":"2017","journal-title":"Cancer Lett."},{"key":"ref_256","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13045-018-0563-y","article-title":"Characterization and validation of potential therapeutic targets based on the molecular signature of patient-derived xenografts in gastric cancer","volume":"11","author":"Chen","year":"2018","journal-title":"J. Hematol. Oncol."},{"key":"ref_257","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.yexcr.2017.09.031","article-title":"Palbociclib-induced autophagy and senescence in gastric cancer cells","volume":"360","author":"Valenzuela","year":"2017","journal-title":"Exp. Cell Res."},{"key":"ref_258","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1007\/s00595-013-0581-x","article-title":"Contribution of Aurora-A and -B expression to DNA aneuploidy in gastric cancers","volume":"44","author":"Honma","year":"2014","journal-title":"Surg. Today"},{"key":"ref_259","doi-asserted-by":"crossref","first-page":"6947","DOI":"10.2147\/CMAR.S254250","article-title":"AURKB Promotes the Metastasis of Gastric Cancer, Possibly by Inducing EMT","volume":"12","author":"Wang","year":"2020","journal-title":"Cancer Manag. Res."},{"key":"ref_260","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/CAD.0000000000000684","article-title":"Aurora kinase B inhibitor barasertib (AZD1152) inhibits glucose metabolism in gastric cancer cells","volume":"30","author":"He","year":"2019","journal-title":"Anti-Cancer Drugs"},{"key":"ref_261","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/CAD.0000000000000928","article-title":"Antitumor activity of a novel Aurora A\/B kinases inhibitor TY-011 against gastric cancer by inducing DNA damage","volume":"31","author":"Jiang","year":"2020","journal-title":"Anti-Cancer Drugs"},{"key":"ref_262","doi-asserted-by":"crossref","first-page":"144937","DOI":"10.1016\/j.gene.2020.144937","article-title":"MicroRNAs in gastric cancer: Biomarkers and therapeutic targets","volume":"757","author":"Vafaee","year":"2020","journal-title":"Gene"},{"key":"ref_263","doi-asserted-by":"crossref","first-page":"19443","DOI":"10.18632\/oncotarget.23821","article-title":"Epigenetic regulation of long non-coding RNAs in gastric cancer","volume":"9","author":"Zhou","year":"2018","journal-title":"Oncotarget"},{"key":"ref_264","doi-asserted-by":"crossref","first-page":"8880","DOI":"10.7150\/thno.47548","article-title":"Long non-coding RNAs in gastric cancer: New emerging biological functions and therapeutic implications","volume":"10","author":"Tan","year":"2020","journal-title":"Theranostics"},{"key":"ref_265","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s12943-020-01185-7","article-title":"Noncoding RNAs in gastric cancer: Implications for drug resistance","volume":"19","author":"Wei","year":"2020","journal-title":"Mol. Cancer"},{"key":"ref_266","doi-asserted-by":"crossref","first-page":"e1864","DOI":"10.1634\/theoncologist.2020-0681","article-title":"Phase II Trial of Palbociclib in Patients with Advanced Esophageal or Gastric Cancer","volume":"25","author":"Karasic","year":"2020","journal-title":"Oncologist"},{"key":"ref_267","doi-asserted-by":"crossref","unstructured":"Malagraba, G., Yarmohammadi, M., Javed, A., Barcel\u00f3, C., and Rubio-Tom\u00e1s, T. (2022). The Role of LSD1 and LSD2 in Cancers of the Gastrointestinal System: An Update. Biomolecules, 12.","DOI":"10.3390\/biom12030462"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/3\/2848\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:21:45Z","timestamp":1760120505000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/3\/2848"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,2]]},"references-count":267,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,2]]}},"alternative-id":["ijms24032848"],"URL":"https:\/\/doi.org\/10.3390\/ijms24032848","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,2]]}}}